RUBICON FDA Approval ANDA 214280

ANDA 214280

RUBICON

FDA Drug Application

Application #214280

Application Sponsors

ANDA 214280RUBICON

Marketing Status

Over-the-counter001

Application Products

001TABLET, ORALLY DISINTEGRATING;ORAL10MG0LORATADINELORATADINE

FDA Submissions

UNKNOWN; ORIG1AP2020-09-10STANDARD

Submissions Property Types

ORIG1Null15

CDER Filings

RUBICON
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214280
            [companyName] => RUBICON
            [docInserts] => ["",""]
            [products] => [{"drugName":"LORATADINE","activeIngredients":"LORATADINE","strength":"10MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/10\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-09-10
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.